New drug combo trial aims to wipe out parasitic infection
NCT ID NCT04410406
Summary
This completed Phase 3 trial compared different drug combinations to treat lymphatic filariasis, a parasitic disease that can cause severe swelling. Researchers tested whether adding a newer drug called moxidectin worked better than the standard ivermectin when combined with other medications. The study followed 164 adults in Côte d'Ivoire for up to 3 years to see which treatment cleared the infection most effectively and safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHATIC FILARIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regional Hospital of Agboville, Southern Cote d'Ivoire
Agboville, Côte d’Ivoire
Conditions
Explore the condition pages connected to this study.